Clinical Trial

Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 17, 2024 (before its estimated January 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to determine the total concentration of selected trace elements (Cu, Zn, Fe), the proportion of free Cu and Cu bound to ceruloplasmin and the isotopic ratio of Cu65/Cu63 in blood serum samples from healthy volunteers and cancer patients using inductively coupled plasma mass spectrometry-based methods. The results will be statistically evaluated and the potential applications of the analytical methods used in cancer diagnosis and therapy will be assessed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-09-27.
Trial Details
NCT Number NCT06060990
Lead Sponsor Institute of Oncology Ljubljana
Conditions Trace Element Deficiency
Enrollment 20 participants
Start Date 2023-01-01
Primary Completion 2025-01-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-17